Login / Signup

Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke.

Paweł LataczTadeusz J PopielaPaweł BrzegowyBartłomiej LasochaKrzysztof KwiecieńMarian Simka
Published in: Neurology international (2024)
The administration of eptifibatide in stroke patients presenting with tandem lesions is relatively safe. Moreover, treatment with this drug can improve clinical outcomes in these challenging patients.
Keyphrases
  • low dose
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • atrial fibrillation
  • prognostic factors
  • emergency department
  • patient reported outcomes
  • adverse drug